REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/28/2025
Back to search
Official data from USPTO
SOURCEPHLEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SOURCEPHLEX
ST13
US500000079246041Class
35, 42, 44, 45
Filing
79246041
Registration
6039116
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
04/29/2025
Trademark type
Word
Nice classes
35, 42, 44, 45
Filing date
01/12/2018
Registration date
04/28/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2020
Last transaction
04/29/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
DE
Examiner
LAVACHE, LINDA
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PharmaLex GmbH
Representatives
Mark J. Liss LEYDIG, VOIT & MAYER, LTD.
Technical classification
Nice Classes
Class 35Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Advertising servicesbusiness management for others; company administration servicesbusiness administration services; providing office functions; business efficiency expert services; systemization of information into computer databases; compilation of information into computer databases; business assistance and consultancy in the context of the retailing and wholesaling of medicines; providing of outsourcing services in the field of medicine authorisationproductionsalesafety and monitoring
Class 42
Scientific and technological services and research and design relating theretoscientific researchlaboratory research in the field of pharmaceuticals; industrial analysis and research services in the field of pharmaceuticals; scientific research and development of new products for others in the field of pharmaceuticals; provision of scientific surveysmedical research surveys; development of a web application for inputting and using informative texts for medicines and medical productsin particular user guidespackaging insertsspecialist informationfor providing various documents; database serviceselectronic storage of data in computer databases; conversion of data or documents from physical to electronic media; research in relation to scientific work; preparation of scientific analysis and assessments; pharmaceutical product evaluation; consultancy pertaining to pharmacology; consultancy relating to research and development in the field of therapeutics; consultancy relating to laboratory testing; pharmaceutical products development; development of pharmaceutical preparations and medicines; testing of pharmaceuticals; provision of information and data relating to medical and veterinary research and development; inspection of pharmaceuticals; scientific investigations for medical purposes; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical drug development services; medical laboratory services; information technology services for the pharmaceutical and healthcare industriesinformation technology consulting services; scientific assessment of the efficiency of medicines; services for assessing the efficiency of pharmaceuticalspharmaceutical product evaluation; scientific analysis and evaluation of product design; scientific analysis and evaluation of product development; quality control testing; materials testing and evaluation; product safety testing; quality control servicestestinganalysis and evaluation of the goods of others to determine conformity with certification standards; quality testing of products to determine conformity with certification standards; assistance and consultancy in the nature of pharmaceutical research in the field of medicine safety and monitoring; pharmaceutical drug development consultancy in the field of medicine safety
Class 44
Medical and veterinary medical services; pharmacy adviceprovision of pharmaceutical advice for pharmaceutical and medical device companies; providing information relating to the preparation and dispensing of medications
Class 45
Public document filing assistance in the field of medicine authorizationpublic document filing services pertaining to documents for authorizing medicines featuring documentsreports and files required by regulatory authorities; regulatory compliance consultancy in the field of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
38 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/15/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/18/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/26/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/06/2020
FIMP
FINAL DISPOSITION PROCESSED
09/01/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/28/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
05/22/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/21/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/22/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/22/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/11/2020
PUBO
PUBLISHED FOR OPPOSITION
02/11/2020
GPNX
NOTIFICATION PROCESSED BY IB
02/07/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/22/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/22/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/22/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/16/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/16/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
12/16/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/16/2019
GNFR
FINAL REFUSAL E-MAILED
07/16/2019
CNFR
FINAL REFUSAL WRITTEN
07/16/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/17/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/17/2019
ALIE
ASSIGNED TO LIE
06/14/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/11/2019
RFNT
REFUSAL PROCESSED BY IB
12/28/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/12/2018
RFRR
REFUSAL PROCESSED BY MPU
12/11/2018
MAFR
APPLICATION FILING RECEIPT MAILED
11/30/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/29/2018
CNRT
NON-FINAL ACTION WRITTEN
11/28/2018
DOCK
ASSIGNED TO EXAMINER
11/26/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/26/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/22/2018
Continuous trademark protection
Get notified about every new filing that threatens SOURCEPHLEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.